Fertility outcomes with ART following fertility-sparing treatment for endometrial neoplasia: a systematic review

E Manguso, EG Thayer, KD Starbuck, A Marsidi - F&S Reviews, 2023 - Elsevier
Objective To review the literature on the fertility outcomes for individuals using assisted
reproductive technologies (ART) following fertility-sparing treatment (FST) for endometrial …

Fertility-sparing treatment and assisted reproductive technology in patients with endometrial carcinoma and endometrial hyperplasia: pregnancy outcomes after …

H Friedlander, JK Blakemore, DH McCulloh, ME Fino - Cancers, 2023 - mdpi.com
Simple Summary Given that younger women with endometrial carcinoma
(EMCA)/endometrial hyperplasia (EH) tend to have better prognoses than older women and …

[HTML][HTML] Pregnancy outcomes after fertility preservation in women with endometrial carcinoma and atypical endometrial hyperplasia: A systematic review and meta …

Z Xiao, Z Song, J Wang, H Liu, Q Lu - Gynecology and Obstetrics Clinical …, 2021 - Elsevier
Objective The objective of the study was to compare the effects of assisted reproductive
technology (ART) and spontaneous pregnancy on pregnancy outcomes in women with …

Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex …

AR Han, YS Kwon, DY Kim, JH Kim, YM Kim… - International Journal of …, 2009 - ijgc.bmj.com
Objectives: To evaluate the outcomes of pregnancy in young women (< 40 years old) with
early endometrial cancer or atypical complex hyperplasia who were treated by conservative …

Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: A systematic review and meta …

S De Rocco, D Buca, L Oronzii, M Petrillo… - European Journal of …, 2022 - Elsevier
Objective To report the pregnancy outcomes of women with prior endometrial cancer and
endometrial hyperplasia managed with fertility-sparing treatments. Methods Medline and …

Fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer: a cochrane systematic review protocol

ME Fernandez-Montoli, J Sabadell… - Advances in …, 2021 - Springer
Introduction Endometrial cancer is the fifth most common cancer in women and atypical
endometrial hyperplasia is a precancerous lesion. Obesity is an important risk factor for …

Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia

Y Wang, R Zhou, H Wang, H Liu, J Wang - International Journal of …, 2019 - ijgc.bmj.com
Objective Fertility preservation is an option for selected patients with endometrial
hyperplasia or cancer. This study aimed to evaluate whether duration of treatment impacts …

[HTML][HTML] Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review

I Murakami, H Machida, T Morisada… - Journal of …, 2023 - ncbi.nlm.nih.gov
Objective To examine the effectiveness of progestin re-treatment for recurrent endometrial
intraepithelial neoplasia (EIN), atypical endometrial hyperplasia (AH) and endometrial …

Pregnancy and obstetric outcomes after fertility-sparing management of endometrial cancer and atypical hyperplasia: a multicentre cohort study

R Vasileva, H Wohrer, V Gaultier, M Bucau… - Human …, 2024 - academic.oup.com
STUDY QUESTION What are the pregnancy and obstetric outcomes in women with atypical
hyperplasia (AH) or early-stage endometrial cancer (EC) managed conservatively for fertility …

IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management

M Vaugon, M Peigné, J Phelippeau, C Gonthier… - Reproductive …, 2021 - Elsevier
Research question Do IVF treatments after conservative management of endometrial
atypical hyperplasia or grade 1 endometrial adenocarcinoma (AH/EC) increase the risk of …